Ehrlichiosis

Ehrlichiosis is a group of infections caused by obligate intracellular Gram-negative bacteria of the genus Ehrlichia. They are spread mainly by the bite of hard ticks, above all the Lone Star tick (Amblyomma americanum). The bacteria invade white blood cells (monocytes and granulocytes) directly, injuring the lining of small blood vessels, causing marked drops in blood cell counts and producing a red papular or hemorrhagic rash on the skin.

At Haute-Derma, catching ehrlichiosis early means putting together atypical skin findings, the characteristic morulae seen on a peripheral blood smear, and prompt high-dose doxycycline to prevent acute respiratory distress syndrome (ARDS), kidney failure and death.

Pathogenesis and Transmission

Causative Organisms and Tick Vectors

  • Human monocytic ehrlichiosis (HME): caused by Ehrlichia chaffeensis and transmitted by the Lone Star tick (Amblyomma americanum).
  • Granulocytic ehrlichiosis: caused by Ehrlichia ewingii or Ehrlichia muris eauclairensis and transmitted by Amblyomma americanum or Ixodes scapularis.

Intracellular Invasion and Morula Formation

  • Entry into white cells: after the tick bite, Ehrlichia enters the bloodstream, binds to surface receptors on monocytes or neutrophils, and is taken into the cytoplasm by phagocytosis.
  • Morula formation: the bacteria multiply inside vacuoles of the host cell and cluster into small mulberry-like masses called morulae.
  • Cell destruction and systemic inflammation: as the bacteria replicate, the white cells burst and release large numbers of new organisms into the blood. This sets off a cytokine storm that damages blood vessel linings throughout the body and leads to low white cell and platelet counts and raised liver enzymes.

Clinical Features

Acute Systemic Symptoms: Onset is sudden, with high fever (above 38.5°C), shaking chills, severe headache (often behind the forehead), muscle aches, profound fatigue, nausea and diarrhea.

Skin Findings (Rash Dynamics)

  • Frequency: a rash appears in roughly 30–40% of adults and in as many as 60–80% of children.
  • Appearance: a red maculopapular rash, an edematous papular rash, or small pinpoint hemorrhages (petechiae).
  • Distribution: the rash usually starts on the trunk, abdomen and thighs before spreading to the limbs. A necrotic eschar at the bite site is usually absent, which helps distinguish it from scrub typhus and some rickettsial infections.

Multiorgan Complications in High-Risk Patients

  • In immunocompromised patients (HIV, organ transplant recipients, those on corticosteroids) and frail older adults, the illness can progress to acute respiratory distress syndrome (ARDS), meningoencephalitis, acute kidney injury, disseminated intravascular coagulation (DIC) and septic shock.

Differential Diagnosis of Tick-Borne Bacterial Infections

Ehrlichiosis (HME)Anaplasmosis (HGA)Rocky Mountain spotted fever (RMSF)
MonocytesGranulocytes (neutrophils)Vascular endothelial cells
Moderate (30–40% of adults)Very rare (< 10%)Very common (> 80–90%)
Rash starts on the trunk and spreads to the limbsNonspecific rashRash starts at the wrists/ankles and spreads to the palms/soles
Morulae in monocytes on blood smearMorulae in neutrophils on blood smearNone
Low white cells, low plateletsLow white cells, low plateletsSeverely low platelets

Our Diagnostic Approach at Haute-Derma

Exposure History: Living in, traveling to, hiking or gardening in an area where the tick (Amblyomma americanum) is common during the 1–2 weeks before symptoms began.

Giemsa/Wright-Stained Peripheral Blood Smear: We look for morulae, dark blue-purple mulberry-shaped clusters of bacteria, in the cytoplasm of monocytes. The finding is highly specific, but its sensitivity is only about 20–30%.

Blood Counts and Chemistry:

  • Complete blood count: leukopenia and thrombocytopenia.
  • Blood chemistry: raised liver enzymes (AST/ALT 2–5 times normal) and elevated LDH.

Molecular Testing (PCR) and Serology:

  • Real-time PCR: the gold standard for early diagnosis, detecting E. chaffeensis DNA in whole blood before antibodies have developed.
  • IFA test: paired IgG/IgM antibody titers, with a more than fourfold rise after 2–4 weeks confirming the diagnosis.

Treatment and Recovery at Haute-Derma

Antibiotic Therapy (First-Line Treatment)

  • Doxycycline (first choice for all patients):
    • Adult dose: 100 mg twice daily, by mouth or intravenously.
    • Pediatric dose (< 45 kg): 2.2 mg/kg twice daily.
    • Duration: continue for at least 3 days after the fever has fully resolved and the patient is clinically better (usually 7–14 days in total).
  • Rifampin (alternative):
    • When used: in pregnancy or in patients with a severe tetracycline allergy.
    • Dose: 300 mg twice daily for 7–10 days.

Assessing Response and Follow-Up

  • Fever usually settles and headache eases noticeably within 24–48 hours of starting doxycycline.
  • Blood counts and liver function are checked daily until they have recovered and remain stable.

Frequently Asked Questions (FAQs)

Experiencing similar symptoms?

Our Haute-Derma specialists are ready to provide expert consultation on Ehrlichiosis — from accurate diagnosis to the most suitable treatment plan for you.

Same-day appointments · Confidential · Minimal wait time

Nhắn tin cho phòng khám

Để lại lời nhắn, tư vấn viên sẽ gọi lại cho bạn trong giờ làm việc. Kênh này không dùng cho tình trạng khẩn cấp: nếu có dấu hiệu nguy hiểm, hãy gọi 115.

Gọi 0329 279 889